← Evidence map

ArticleCNS drugs2015

Cost effectiveness of fingolimod, teriflunomide, dimethyl fumarate and intramuscular interferon-β1a in relapsing-remitting multiple sclerosis.

Xinke Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

12 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25326785